- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Latest Triple Combination of Empagliflozin, Sitagliptin and Metformin for Advanced Care in Indian T2DM Patients - When to Consider? - Video
Overview
In this episode of The Diabetes Wellness Forum, titled "Importance of Early Aggressive Glucose Control-Approach in 2025," Dr Nandita Mohan from Medical Dialogues is in conversation with Dr Vaishali Deshmukh, Consultant Diabetologist & Endocrinologist at Deenanath Mangeshkar Hospital, Pune, Maharashtra and Dr Altamash Shaikh, Consultant Endocrinologist & Diabetologist and Metabolic Physician, Saifee Hospital, Mumbai, Maharashtra, to discuss a critical aspect of diabetes care in 2025.
With Type 2 diabetes increasingly affecting younger individuals in India and showing rapid disease progression, early and effective glucose control has become essential to prevent long-term microvascular and macrovascular complications. It highlights real-world strategies and contemporary approaches to early aggressive glucose management in 2025.
During this episode, the experts address three key clinical questions:
1. What is the burden of uncontrolled Type 2 diabetes and the major clinical challenges in managing these patients?
2. What is the clinical utility of the empagliflozin, sitagliptin, and metformin combination in uncontrolled Type 2 diabetes?
3. Which patient profiles are best suited for empagliflozin, sitagliptin, and metformin fixed-dose combination therapy?


